Acral Lentiginous Melanoma
📧 Sign up to get email alerts when something new happens for Acral Lentiginous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease [Phase 1]
Phase 1 study evaluating intravenous and intrathecal nivolumab for leptomeningeal disease in melanoma and non-small cell lung cancer patient…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases [Phase 2]
Phase 2 study compares encorafenib + binimetinib + nivolumab versus ipilimumab + nivolumab in BRAF-V600 mutation melanoma with brain metasta…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in advanced/metastatic acral lentiginous melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab [Phase 2]
Phase 2 trial studying nivolumab plus ipilimumab in advanced acral lentiginous melanoma and mucosal melanoma; terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma [Phase 2]
Phase 2 trial evaluating the timing of pembrolizumab around surgery in high-risk melanoma, comparing post-operative administration to strate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread [Phase 2]
A completed Phase 2 trial evaluated nilotinib for metastatic acral lentiginous melanoma and mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma [Phase 2]
Phase 2 trial results for SU011248 in metastatic mucosal melanoma and acral lentiginous melanoma; the study is completed and results were po…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma [Phase 2]
Phase 2 clinical trial evaluating imatinib in mucosal melanoma, acral lentiginous melanoma, and chronically sun-damaged melanomas. The study…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma [Phase 2]
Phase 2 trial of dasatinib in acral lentiginous, mucosal, or chronic sun-damaged melanoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate for patients with unresectable stage III or stage IV melanoma, including acral lentigino…